Trial
NCT04450836
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
UNICANCER
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
Regorafenib then Trifluridine/Tipiracil
Why stopped
Following the presentation of the SUNLIGHT study results at ASCO GI and the rapid change in patient management in the majority of centers, the IDMC experts recommended halting inclusion in the SOREGATT study with immediate effect.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-30